Lotus Eye Hospital & Institute Stock Performance
as on August 20, 2026 at 9:31 pm IST
Day's Low
Day's High
₹115.25₹119.00
1.59%
Downside
1.61%
Upside

52 Week's Low
52 Week's High
₹77.19₹147.00
34.09%
Downside
25.52%
Upside

Lotus Eye Hospital & Institute share price movements today
- Previous Close
- ₹115.51
- Open
- ₹117.82
- Volume
- 15.84K
- Upper Circuit
- ₹138.61
- Lower Circuit
- ₹92.41
- Day's Low - High
- ₹115.25 - ₹119.00
- 52 Week Low - High
- ₹77.19 - ₹147.00
Lotus Eye Hospital & Institute Historical Returns
- 1 Month Return
- -4.87 %
- 3 Month Return
- + 5.76 %
- 1 Year Return
- + 33.4 %
- 3 Year Return
- + 37.1 %
- 5 Year Return
- + 163.42 %
Lotus Eye Hospital & Institute Fundamentals
as on August 20, 2026 at 4:01 pm IST
Market Cap
₹240.22 Cr
Return on Equity (ROE)
1.24
PE Ratio (TTM)
0Return on capital employed (ROCE)
2.99
Industry PE ratio
-
Beta (LTM)
0.76
P/B Ratio
2.42
Dividend Yield
0PEG Ratio
0Quarterly Earnings Growth YOY
12.96
EPS (TTM)
0Book Value
0Lotus Eye Hospital & Institute Technical Analysis
Track how Lotus Eye Hospital & Institute technical analysis has moved over time to understand its trends.
Technicals Summary
Bearish
Neutral
Bullish
Moving Averages
Bearish
Neutral
Bullish
Oscillators
Bearish
Neutral
Bullish
Overall
Oscillators
Name | Value | Action |
|---|---|---|
MACD level (12,26) | 0.51 | Bullish |
CCI (20) | 64.63 | Neutral |
RSI (14) | 88.55 | |
Momentum (10) | 0 | |
ADI (14) | 45.41 | Bullish |
Ultimate Oscillator (7,14,28) | 67.15 | Neutral |
Moving Averages
Name | Value | Action |
|---|---|---|
SMA (20) | 117.14 | Bullish |
EMA (20) | 117.33 | Bullish |
VWMA (20) | 117.57 | Bullish |
SMA (50) | 116.4 | Bullish |
EMA (50) | 116.74 | Bullish |
SMA (200) | 115.99 | Bullish |
EMA (200) | 116.3 | Bullish |
KAMA (200) | 117.45 | Bullish |
DEMA (200) | 116.36 | Bullish |
Lotus Eye Hospital & Institute Ltd vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Lotus Eye Hospital & Institute with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 240.22 | 32.68% | 0.00 | 2 | 49 | |
| NA | 11.05 | -12.7% | 0.00 | NA | 3 | |
| NA | 256.34 | 131.88% | 0.00 | NA | NA | |
| NA | 78.87 | -4.38% | 0.00 | 6 | 66 | |
| HOLD | 1,606.69 | -5.21% | 0.65 | 30 | 252 |
Lotus Eye Hospital & Institute Stock’s Investor Sentiment and Interest
Search interest for Lotus Eye Hospital & Institute Ltd Stock has decreased by -20% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Lotus Eye Hospital & Institute Ltd Quarterly Profit & Loss
Figures in Rupees Crores
Lotus Eye Hospital & Institute Ltd Annual Profit & Loss
Figures in Rupees Crores
Lotus Eye Hospital & Institute Ltd Cash Flow
Figures in Rupees Crores
Lotus Eye Hospital & Institute Corporate Actions
View detailed summary of the earnings and dividend history of Lotus Eye Hospital & Institute.
Lotus Eye Hospital & Institute Ltd Earnings Results
Lotus Eye Hospital & Institute Ltd’s net profit jumped 12.96% since last year same period to ₹0.61Cr in the Q1 2026-2027. On a quarterly growth basis, Lotus Eye Hospital & Institute Ltd has generated 290.63% jump in its net profits since last 3-months.
Read More about Earnings ResultsLotus Eye Hospital & Institute Ltd Dividends May,2023
In the quarter ending March 2023, Lotus Eye Hospital & Institute Ltd has declared dividend of ₹0.50 per share on 24 May 2023 - translating a dividend yield of 0.87%.
Read More about Dividends
Insights on Lotus Eye Hospital & Institute Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTBest in 1 Year

In the last 1 year, LOTUSEYE has outperformed top 5 stocks with highest market-cap in Healthcare Facilities & Services
POSITIVE IMPACTPrice Rise

In the last 1 year, LOTUSEYE stock has moved up by 33.4%
POSITIVE IMPACTRetail Holding Up

Retail Investor have increased holdings from 59.84% to 59.85% in Jun 2026 quarter
NO EFFECTPromoter Holding Unchanged

Promoters holdings remained unchanged at 40.14% of holdings in Jun 2026 quarter
NO EFFECTAgainst Peers

In the last 3 years, Fortis Healthcare Ltd has given 183.0% return, outperforming this stock by 145.9%
About Lotus Eye Hospital & Institute Ltd
Revenue: ₹17.06Cr as on June 2026 (Q1 FY27)
Net Profit: ₹0.61Cr as on June 2026 (Q1 FY27)
Listing date: 11 Jul, 2008
Chairperson Name: Kaveetha Sundaramoorthy
| Organisation | Lotus Eye Hospital & Institute Ltd |
| Industry | Healthcare |
| CEO | Kaveetha Sundaramoorthy |
| E-voting on shares | Click here to vote |
FAQs
What is Lotus Eye Hospital & Institute share price today?
Lotus Eye Hospital & Institute share price today stands at ₹117.11 as on at the close of the market. Lotus Eye Hospital & Institute share today touched a day high of ₹119 and a low of ₹115.25.
What is the 52 week high and 52 week low range for Lotus Eye Hospital & Institute share?
Lotus Eye Hospital & Institute touched a 52 week high of ₹147 and a 52 week low of ₹77.19. Lotus Eye Hospital & Institute share price today i.e. is closed at ₹117.11, which is -20.33% down from its 52 week high and 51.72% up from its 52 week low.
What is Lotus Eye Hospital & Institute's market capitalisation today?
Lotus Eye Hospital & Institute market capitalisation is ₹240.22 Cr as on .
How to buy Lotus Eye Hospital & Institute shares?
To buy Lotus Eye Hospital & Institute shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for LOTUSEYE or Lotus Eye Hospital & Institute Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Lotus Eye Hospital & Institute shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is Lotus Eye Hospital & Institute trading volume today?
Lotus Eye Hospital & Institute trading volume is 15.84K as on . This means that 15.84K shares of Lotus Eye Hospital & Institute were bought and sold on the stock market during today's trading session.